menu search

Bristol myers shares interim data from long-term study of zeposia in ulcerative colitis

Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term effi...

February 17, 2022, 3:41 pm

Bristol myers shares interim data from long-term study of zeposia in ulcerative colitis

Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term effi...

February 17, 2022, 3:41 pm

Bristol myers shares interim data from long-term study of zeposia in ulcerative colitis

Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term effi...

February 17, 2022, 3:41 pm

Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms

Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy tria...

February 17, 2022, 11:40 am

Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms

Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy tria...

February 17, 2022, 11:40 am

Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms

Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy tria...

February 17, 2022, 11:40 am

Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients

Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...

February 17, 2022, 11:11 am

Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients

Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...

February 17, 2022, 11:11 am

Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients

Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...

February 17, 2022, 11:11 am

Los andes copper announces appointment of santiago montt as its chief operating officer

Los Andes Copper Ltd (TSX-V:LA) has announced the appointment of Santiago Montt as its chief operating officer (COO) and as president of Compañía Mi...

February 15, 2022, 10:03 am

Los andes copper announces appointment of santiago montt as its chief operating officer

Los Andes Copper Ltd (TSX-V:LA) has announced the appointment of Santiago Montt as its chief operating officer (COO) and as president of Compañía Mi...

February 15, 2022, 10:03 am

Los andes copper announces appointment of santiago montt as its chief operating officer

Los Andes Copper Ltd (TSX-V:LA) has announced the appointment of Santiago Montt as its chief operating officer (COO) and as president of Compañía Mi...

February 15, 2022, 10:03 am

Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens

Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...

February 11, 2022, 8:42 am

Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens

Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...

February 11, 2022, 8:42 am

Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens

Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...

February 11, 2022, 8:42 am

Novavax stock rises as covid vaccine shows 80% efficacy in adolescents

Novavax will submit applications for clearance of the shot's use in adolescents to global authorities in first quarter...

February 11, 2022, 5:32 am

Novavax stock rises as covid vaccine shows 80% efficacy in adolescents

Novavax will submit applications for clearance of the shot's use in adolescents to global authorities in first quarter...

February 11, 2022, 5:32 am

Novavax stock rises as covid vaccine shows 80% efficacy in adolescents

Novavax will submit applications for clearance of the shot's use in adolescents to global authorities in first quarter...

February 11, 2022, 5:32 am

Los andes copper reports encouraging assays from its phase i drill program at the vizcachitas copper project in chile

Los Andes Copper Ltd (TSX-V:LA) reported “excellent” drill results from its Vizcachitas copper proj...

February 10, 2022, 9:34 am

Los andes copper reports encouraging assays from its phase i drill program at the vizcachitas copper project in chile

Los Andes Copper Ltd (TSX-V:LA) reported “excellent” drill results from its Vizcachitas copper proj...

February 10, 2022, 9:34 am


Search within

Pages Search Results: